The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
Open accessAbstract
SUMMARY Ovarian cancer has a clear predilection for metastasis to the omentum, but the underlying mechanisms involved in ovarian cancer spread are not well understood. Here, we used a parabiosis model that demonstrates preferential hematogenous metastasis of ovarian cancer to the omentum. Our studies revealed that the ErbB3-neuregulin1 (NRG1) axis is a dominant pathway responsible for hematogenous omental metastasis. Elevated levels of ErbB3 in ovarian cancer cells and NRG1 in the omentum allowed for tumor cell localization and growth in the omentum. Depletion of ErbB3 in ovarian cancer impaired omental metastasis. Our results highlight hematogenous metastasis as an important mode of ovarian cancer metastasis. These findings have implications for designing alternative strategies aimed at preventing and treating ovarian cancer metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103799 · Cited by 2,172
Aghajanian, C., Blank, S. V., Goff, B. A., Judson, P. L., Teneriello, M. G., Husain, A., Sovak, M. A., Yi, J., & Nycum, L. R. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.0505 · Cited by 1,384
HEINTZ, A., ODICINO, F., MAISONNEUVE, P., QUINN, M., BENEDET, J., CREASMAN, W., NGAN, H., PECORELLI, S., & BELLER, U. (2006) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(06)60033-7 · Cited by 1,277
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Paraneoplastic thrombocytosis in ovarian cancer
Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110352 · Cited by 812
Self-citationDicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., Urbauer, D., Pennacchio, L. A., Cheng, J.-F., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 712
Self-citationTherapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
Self-citationOvarian Cancer Metastasis: Integrating insights from disparate model organisms
Naora, H., & Montell, D. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1611 · Cited by 538
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
Self-citationRegulation of Tumor Angiogenesis by EZH2
Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., Armaiz-Pena, G. N., Hu, W., Stone, R. L., Munkarah, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.016 · Cited by 399
Self-citationMechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.
Tarin, D., Price, J. E., Kettlewell, M. G. W., Souter, R. G., Ac, V., & Crossley, B. (1984) · PubMed · Cited by 303
Adam, L., Vadlamudi, R., Kondapaka, S. B., Chernoff, J., Mendelsohn, J., & Kumar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28238 · Cited by 284
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Self-citationAn ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation
Schoeberl, B., Faber, A. C., Li, D., Liang, M.-C., Crosby, K., Onsum, M., Burenkova, O., Pace, E., Walton, Z., Nie, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3145 · Cited by 264
Gordon, M. S., Matei, D., Aghajanian, C., Matulonis, U. A., Brewer, M., Fleming, G. F., Hainsworth, J. D., Garcia, A. A., Pegram, M. D., Schilder, R. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4221 · Cited by 252
A Novel Platform for Detection of CK+ and CK− CTCs
Pecot, C. V., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Bottsford-Miller, J., Stone, R. L., Lin, Y. G., Jaladurgam, P., Roh, J. W., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0215 · Cited by 217
Self-citationEphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Thaker, P. H., Deavers, M., Celestino, J., Thornton, A., Fletcher, M. S., Landen, C. N., Kinch, M. S., Kiener, P. A., & Sood, A. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0589 · Cited by 211
Self-citationSingh, M., Zaino, R. J., Filiaci, V. J., & Leslie, K. K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.03.042 · Cited by 165
Circulating Monocytes Expressing CD31
Kim, S., Kim, J., Papadopoulos, J. N., Kim, S. W., Maya, M., Zhang, F., He, J., Fan, D., Langley, R. R., & Fidler, I. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080819 · Cited by 155
Self-citationAhmed, A. A., Lü, Z., Jennings, N. B., Etemadmoghadam, D., Capalbo, L., Jacamo, R. O., Barbosa‐Morais, N. L., Le, X., Vivas‐Mejía, P. E., Lopez‐Berestein, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.018 · Cited by 152
Self-citationKomurov, K., Tseng, J., Muller, M., Seviour, E. G., Moss, T. J., Yang, L., Nagrath, D., & Ram, P. T. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.25 · Cited by 130
Self-citationNetWalker: a contextual network analysis tool for functional genomics
Komurov, K., Dursun, S., Erdin, S., & Ram, P. T. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-282 · Cited by 107
Self-citationApte, S. M., Bucana, C. D., Killion, J. J., Gershenson, D. M., & Fidler, I. J. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.041 · Cited by 92
Self-citationPhillips, K. G., Velasco, C. R., Li, J., Kolatkar, A. R., Luttgen, M. S., Bethel, K. J., Duggan, B. D., Kühn, P., & McCarty, O. J. T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00072 · Cited by 91
Komurov, K., White, M. A., & Ram, P. T. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000889 · Cited by 89
Self-citationMetronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
Lee, S. J., Ghosh, S. C., Han, H. D., Stone, R. L., Bottsford-Miller, J. N., Shen, D.-Y., Auzenne, E. J., Lopez-Araujo, A., Lü, C., Nishimura, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3250 · Cited by 49
Self-citationHER3 mRNA as a predictive biomarker in anticancer therapy
Amler, L. C. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.512003 · Cited by 18
Cited by
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Self-citationIntegrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Keller, L., & Pantel, K. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0180-2 · Cited by 544
Systems Biology of Cancer Metastasis
Suhail, Y., Cain, M. P., Vanaja, K., Kurywchak, P. A., Levchenko, A., Kalluri, R., & Kshitiz (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.003 · Cited by 452
Yin, M., Li, X., Tan, S., Zhou, H. J., Ji, W., Bellone, S., Xu, X., Zhang, H., Santin, A. D., Lou, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87252 · Cited by 417
Metadata
- Authors
- Pradeep, S., Kim, S. W., Wu, S. Y., Nishimura, M., Chaluvally-Raghavan, P., Miyake, T., Pecot, C. V., Kim, S.-J., Choi, H. J., Bischoff, F. Z., Mayer, J. A., Huang, L., Nick, A. M., Hall, C. S., Rodriguez-Aguayo, C., Zand, B., Dalton, H. J., Arumugam, T., Lee, H. J., Han, H. D., Cho, M. S., Rupaimoole, R., Mangala, L. S., Sehgal, V., Oh, S. C., Liu, J., Lee, J.-S., Coleman, R. L., Ram, P., Lopez-Berestein, G., Fidler, I. J., & Sood, A. K.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 26
- Issue
- 1
- Pages
- 77-91
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2088356680
- Cited by
- 311
- References
- 28
- FWCI
- 25.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.